Most drugs are develooped with a specific indication, without ever investigating the efficacy against other diseases. This article describes the benefits of drug repurposing over traditional drug development, and the scientific methods used to identify new uses of a drug….
Read MoreMinirin Injection
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MINIRINĀ® Injection desmopressin acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MINIRIN Injection. It does not contain all the…
Read MoreAPO-Ramipril Tablets
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-RAMIPRIL TABLETS Ramipril Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ramipril. It does not contain all the available information….
Read MoreVexazone
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VEXAZONE contains the active ingredient pioglitazone hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Vexazone. It does not contain…
Read MoreCefepime Alphapharm
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CEFEPIME ALPHAPHARM contains the active ingredient cefepime hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Cefepime Alphapharm. It does…
Read MoreAPOTEX-Pantoprazole
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOTEX- PANTOPRAZOLE TABLETS Contains the active ingredient, pantoprazole (as sodium sesquihydrate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about pantoprazole….
Read More